tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences Cash flow

88 Followers

Annexon Biosciences Cash Flow

ANNX's free cash flow for Q2 2022 was $-29.02M. For the 2022 fiscal year, ANNX's free cash flow was decreased by $-54.21M and operating cash flow was $-28.16M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -116.49M$ -106.11M$ -53.09M$ -28.36M$ -17.19M
Investing Cash Flow
$ 120.38M$ -88.24M$ -83.16M$ -267.00K$ -17.00K
Financing Cash Flow
$ 1.01M$ 1.79M$ 360.88M$ 28.39M$ 58.46M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 365.33M$ 76.01M$ 268.56M$ 43.93M$ 44.17M
Income Tax Paid Supplemental Data
--$ 0.00$ 2.00K$ 1.00K
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
-$ 0.00$ 369.02M$ 30.00M$ 58.34M
Issuance Of Debt
-$ 0.00$ 500.00K$ 0.00-
Repayment Of Debt
-$ 0.00$ -500.00K$ 0.00-
Free Cash Flow
$ -124.19M$ -107.76M$ -53.55M$ -28.63M$ -17.21M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Annexon Biosciences Cash Flow


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis